aTyr Pharma, Inc. (ATYR)

aTyr Pharma, Inc. (ATYR) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $16.8M; returns 1 day -2.9%, 1 week -5.1%, 1 year -83.0%.

aTyr Pharma, Inc. is a clinical-stage biotechnology company that discovers and develops novel protein-based therapies. The company's focus is on modulating the extracellular matrix and immune pathways for treating rare and serious diseases. aTyr Pharma's proprietary Extracellular Modulation® platform identifies and optimizes biologic candidates.

Groups ATYR belongs to

• Biotechnology
• Biopharmaceutical
• Clinical Stage Biotech
• Clinical Stage
• Healthcare
• Life Sciences
• Rare Diseases
• Biologics
• Immunotherapy
• Drug Discovery
• R&D

ATYR financial model: income statement, cash flow and balance sheet